Clathrin-independent entry of baculovirus triggers uptake of E. coli in non-phagocytic human cells
Laakkonen, J., Mäkelä, A., Kakkonen, E., Turkki, P., Kukkonen, S., Peränen, J., YläHerttuala, S., Airenne, K., Oker-Blom, C., Vihinen-Ranta, M., & Marjomäki, V. (2009). Clathrin-independent entry of baculovirus triggers uptake of E. coli in non-phagocytic human cells. Plos One, 4(4). https://doi.org/10.1371/journal.pone.0005093
Published in
Plos OneAuthors
Date
2009Copyright
© 2009 Laakkonen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License.
The prototype baculovirus, Autographa californica multiple nucleopolyhedrovirus, an insect pathogen, holds great potential
as a gene therapy vector. To develop transductional targeting and gene delivery by baculovirus, we focused on
characterizing the nature and regulation of its uptake in human cancer cells. Baculovirus entered the cells along fluid-phase
markers from the raft areas into smooth-surfaced vesicles devoid of clathrin. Notably, regulators associated with
macropinocytosis, namely EIPA, Pak1, Rab34, and Rac1, had no significant effect on viral transduction, and the virus did not
induce fluid-phase uptake. The internalization and nuclear uptake was, however, affected by mutants of RhoA, and of Arf6, a
regulator of clathrin-independent entry. Furthermore, the entry of baculovirus induced ruffle formation and triggered the
uptake of fluorescent E. coli bioparticles. To conclude, baculovirus enters human cells via a clathrin-independent pathway,
which is able to trigger bacterial uptake. This study increases our understanding of virus entry strategies and gives new
insight into baculovirus-mediated gene delivery in human cells.
...
Publisher
Public Library of ScienceISSN Search the Publication Forum
1932-6203Keywords
Original source
http://www.ncbi.nlm.nih.gov/pubmed/19352496?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=2Publication in research information system
https://converis.jyu.fi/converis/portal/detail/Publication/19117125
Metadata
Show full item recordCollections
License
Except where otherwise noted, this item's license is described as © 2009 Laakkonen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Related items
Showing items with similar title or keywords.
-
6-O sulfated and N-sulfated Syndecan-1 promotes baculovirus binding and entry into mammalian cells.
Makkonen, Emilia; Turkki, Paula; Laakkonen, Johanna; YläHerttuala, Seppo; Marjomäki, Varpu; Airenne, Kari (American Society for Microbiology, 2013)Baculoviruses are insect-specific viruses commonly found in nature. They are not able to replicate in mammalian cells but can transduce them when equipped with an appropriate mammalian cell active expression cassette. ... -
Cell susceptibility to baculovirus transduction and echovirus infection is modified by protein kinase C phosphorylation and vimentin organization.
Turkki, Paula; Makkonen, Emilia; Huttunen, Moona; Laakkonen, Johanna; YläHerttuala, Seppo; Airenne, Kari; Marjomäki, Varpu (American Society for Microbiology, 2013)Some cell types are more susceptible to viral gene transfer or virus infection than others, irrespective of the number of viral receptors or virus binding efficacy on their surfaces. In order to characterize the ... -
A brain cytokine-independent switch in cortical activity marks the onset of sickness behavior triggered by acute peripheral inflammation
Kurki, Samu N.; Ala-Kurikka, Tommi; Lipponen, Arto; Pospelov, Alexey S.; Rolova, Taisia; Koistinaho, Jari; Voipio, Juha; Kaila, Kai (BioMed Central, 2023)Systemic inflammation triggers protective as well as pro-inflammatory responses in the brain based on neuronal and/or cytokine signaling, and it associates with acutely and protractedly disrupted cognition. However, the ... -
Development of baculovirus display strategies towards targeting to tumor vasculature
Matilainen, Heli (University of Jyväskylä, 2006)Matilaisen väitöstutkimuksen tavoitteena oli kehittää bakulovirusta käytettäväksi geeniterapiaan syövän hoitoon. Bakulovirus on hyönteisvirus ja siten turvallisempi vaihtoehto kokeellisessa geeniterapiassa tällä hetkellä ...